GlobeImmune Revenue, Profits - GBIM Quarterly Income Statement

Add to My Stocks
$0.25 $0.05 (16.67%) GBIM stock closing price Sep 25, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the GlobeImmune stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement for GBIM which shows a YOY revenue growth of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the GlobeImmune profit and loss statement for 2016 Q1 total to $0. This line item shows that the operating expenses has decreased compared with last year. Also check: GlobeImmune assets and GlobeImmune free cash flow.

View and download details of revenue and profits for GlobeImmune for latest & last 40 quarters.
show more
Fiscal year is Jan - Dec2016 Q1
GlobeImmune Revenues or Net Sales
Cost Of Goods Sold (COGS)-
GlobeImmune Gross Profit
Research & Development Expense-
Selling General & Admin Expense-
Income Before Depreciation Depletion Amortization-0.84M
Depreciation Depletion Amortization-
Non Operating Income-
Interest Expense-
GlobeImmune Pretax Income
Provision for Income Taxes-
Investment Gains Losses-
Other Income-
Income Before Extraordinaries & Disc Operations-0.86M
Extraordinary Items & Discontinued Operations-
GlobeImmune Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS5.75M
Average Shares used to compute Basic EPS5.75M
Income Before Nonrecurring Items-0.86M
Income from Nonrecurring Items-
GlobeImmune Earnings Per Share Basic Net
GlobeImmune Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.15
Preferred Dividends Acc Pd-
Dividends Common-
Dividend Per Share Common0.00
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing GlobeImmune stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this quarter of 2016 Q1. Our GlobeImmune revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like GlobeImmune try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the GBIM income statement, one can check the GlobeImmune historical stock prices to check how the price has moved with time.

GlobeImmune Income Statement - Key Financial Ratios